Manufacturing: Page 40
-
Seattle Genetics on a building, hiring frenzy
The company has grown rapidly and plans to continue doing so, buoyed by a $552 million secondary stock offering in September.
By Joe Cantlupe • Oct. 6, 2016 -
Merck closes doors at Florida plant
The drugmaker will lay off 112 employees as part of its decision to shutter the Miami Lakes facility.
By Suzanne Elvidge • Oct. 6, 2016 -
Cambrex opens new API plant, continuing investment push
Over the past three months, the New Jersey CMO has announced nearly $60 million in manufacturing investments in addition to acquiring PharmaCore, Inc.
By Suzanne Elvidge • Oct. 6, 2016 -
Evotec inks deal with C4X Discovery
The drug discovery companies aim to collaboratively develop drugs targeting cancer and autoimmune diseases.
By Joe Cantlupe • Sept. 29, 2016 -
In cost-cutting move, AstraZeneca closing its PA offices
The U.K. company is shuttering a Pennsylvania plant and relocating jobs to Delaware, where the company intends to maintain its U.S. headquarters.
By Joe Cantlupe • Sept. 29, 2016 -
FDA
FDA cites Chinese manufacturers for GMP lapses
One firm, Hebei Yuxing, was placed on the regulator's import ban list, which currently includes 54 Chinese suppliers.
By Ned Pagliarulo • Sept. 29, 2016 -
Imprimis shuts down Texas plant, axes 8% of jobs
The drug compounder is cutting its staff as it focuses attentions on its New Jersey facility.
By Suzanne Elvidge • Sept. 29, 2016 -
Genentech commits $80M upfront in Hanmi licensing deal
The Roche subsidiary will have sole rights to commercialize Hanmi’s tumor-suppressing drug outside of South Korea.
By Jacob Bell • Sept. 29, 2016 -
Sonoco ThermoSafe buys Laminar Medica
The Illinois-based packing provider will acquire the UK-based pallet shipping producer to strengthen its shipping capabilities for biopharma companies.
By Joe Cantlupe • Sept. 22, 2016 -
FDA approval in hand, Sarepta plans for future studies
The Cambridge-based biotech announced plans for a proposed $225 million stock offering to fund further clinical testing on and production of eteplirsen.
By Ned Pagliarulo • Sept. 22, 2016 -
GE Healthcare uncorks plans for Irish biopharma park
The medical technology company will invest in a new facility in Cork, Ireland, to help expand bio-manufacturing in the country.
By Joe Cantlupe • Sept. 22, 2016 -
Moderna lifts curtain on manufacturing plant plans
With yet another funding round complete, the messenger RNA biotech will invest $110 million to build-out a new plant in Massachusetts.
By Ned Pagliarulo • Sept. 22, 2016 -
PCT spears a cancer deal with Adaptimmune
The new agreement expands an existing collaboration between the two companies, and will cover cancer immunotherapy manufacturing.
By Suzanne Elvidge • Sept. 22, 2016 -
Momenta, BioFactura team up on biosimilars
With a number of aging, yet still top-selling, biologics nearing patent expiry, biosimilar development in the U.S. is gaining steam.
By Suzanne Elvidge • Sept. 22, 2016 -
Horizon opens up cell lines to researchers
A partnership with two high-profile research organizations will allow groups to license access to the cell lines for research into biologics.
By Lisa LaMotta • Sept. 15, 2016 -
Lonza builds out gene therapy offerings
A new licensing deal with Mass Eye and Ear will give the Swiss contracting giant access to an AAV vector platform, important for development of new gene therapies.
By Ned Pagliarulo • Sept. 15, 2016 -
Novo pulls 71,000 kits of glucagon med from US market
The Danish drugmaker issued the recall of GlucaGen Hypokits after two customer complaints flagged detached needles.
By Ned Pagliarulo • Sept. 15, 2016 -
CMOs speed Citius Pharmaceuticals into Phase 3
Citius has brought on two CMOs to produce Mino-Lok for the clinical trial, which is slated to begin in 2017.
By Suzanne Elvidge • Sept. 15, 2016 -
Avara snaps up AstraZeneca plant
AstraZeneca had planned to close the England-based plant, which employs more than 200 employees.
By Lisa LaMotta • Sept. 8, 2016 -
Fresh off new funding, Moderna plans new manufacturing plant
The Cambridge-based biotech recently raised $474 million to add to its impressive cash haul.
By Ned Pagliarulo • Sept. 8, 2016 -
Cambrex expands manufacturing in Sweden
The New Jersey-based small molecule manufacturer opened a new facility to build out its large-scale capacity.
By Lisa LaMotta • Sept. 8, 2016 -
FDA
FDA renews ban on Indian drugmaker after fresh violations
Pan Drugs failed to maintain basic sanitary standards at its Vandodara facility, and FDA inspectors uncovered evidence of falsified documents.
By Ned Pagliarulo • Sept. 8, 2016 -
Onconova cuts staff further to save cash
The newest layoffs follow earlier job cuts back in February and are aimed at conserving funds in the wake of Baxalta cutting ties on a collaboration.
By Suzanne Elvidge • Sept. 1, 2016 -
In wake of generics deal, Teva to close New York plant
Closure of the Ponoma, New York-based facility would affect approximately 80 jobs, the Israeli generics maker said.
By Ned Pagliarulo • Sept. 1, 2016 -
Theranos stumbles in efforts to sell Zika test: report
The troubled blood-testing company withdrew its application for emergency use of the test after an FDA inspection, according to news reports.
By Ned Pagliarulo • Sept. 1, 2016
Previous
